In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Medtronic exhibits significant upside potential with a fair value 65.6% above current price, supported by a high-confidence DCF midpoint of $193.04. Financial health is solid, especially liquidity and leverage, though growth scores are low. Monte Carlo analysis shows high volatility but limited downside risk (15.6%), indicating asymmetric opportunity with elevated uncertainty.